The Genetic Basis and Molecular Mechanisms of Neurodegeneration
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 97
Special Issue Editor
Interests: genetic basis and molecular mechanisms of neurodegeneration; Alzheimer’s disease; rare neurogenetic disorders; whole-exome sequencing analyses; neurogenetics; hereditary polyneuropathy; hereditary myopathy; hereditary dementia; tardbp; frontotemporal dementia; C9orf72; amyotrophic lateral sclerosis; MAPT; glutamate metabolism
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neurodegenerative disorders include heterogeneous conditions such as Alzheimer’s disease; frontotemporal, Lewy body, and other dementias; Parkinson’s disease; amyotrophic lateral sclerosis; Huntington’s disease; and prion disorders. These disorders pose an important public health threat given their increasing prevalence due to population aging worldwide. This awareness has encouraged efforts to decipher the genetic and molecular mechanisms underlying these disorders with the aim of developing rational therapeutic approaches.
Despite their phenotypic diversity, neurodegenerative disorders frequently overlap on clinical grounds and share common pathophysiological mechanisms, such as protein misfolding, defective protein degradation, mitochondrial dysfunction, impaired axonal transport, DNA repeat expansions, DNA damage, excitotoxicity, oxidative stress, and aberrant programmed cell death. Accordingly, pathological studies have shown both distinct and common histological features in the brains of patients with neurodegenerative disorders. Concerning the genetic basis of these disorders, they are characterized by phenotypic and genotypic heterogeneity, with pathogenic or predisposing variants in a single gene associated with various phenotypes, and, on the other hand, a single phenotype caused by variants in different genes.
The aim of this Special Issue is to include studies that showcase both common and divergent aspects of neurodegenerative disorders, including their genetic and molecular basis, thus advancing knowledge in the field.
Dr. Ioannis V. Zaganas
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Alzheimer’s disease
- amyotrophic lateral sclerosis
- Huntington’s disease
- prion disorders
- protein misfolding
- mitochondrial dysfunction
- DNA damage
- oxidative stress
